ANGPTL4 patch may improve hard-to-heal skin lesions for diabetic patients
Scientists have developed a new gel patch prototype that could speed up the healing of a skin wound while minimising the formation of scars...
List view / Grid view
Scientists have developed a new gel patch prototype that could speed up the healing of a skin wound while minimising the formation of scars...
UCB has announced that the EC has approved the use of its anti-epileptic drug Vimpatas in the treatment of partial-onset seizures...
A new treatment for osteoporosis provides major improvements in bone density and fractures than the current standard treatment...
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
Older people who use steroid inhalers are more likely to suffer particular bacterial infections...
Researchers have found that beta blockers are not needed after a heart attack if survivors are taking ACE inhibitors and statins...
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment...
Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered...
A study has found that a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels...
Researchers have developed microscale devices that relay their location in the body...
By incorporating magnetic nanoparticles in cells researchers have succeeded in creating cellular magnetic "Legos."...
Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy, a current study has investigated the underlying mechanisms of this action...
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
Alternative immunotherapy drug nivolumab is more effective than current standard of care in treating advanced melanoma after surgical removal of disease.
Pembrolizumab has shown a promising response rate in patients with pre-treated metastatic gastric cancer, according to results from the KEYNOTE-059 trial...